Article
The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.
Oncogene - 1 Sept 2021
Rugolo Francesco, Bazan Nicolas G, Calandria Jorgelina, Jun Bokkyoo, Raschellà Giuseppe, Melino Gerry, Agostini Massimiliano
Abstract excerpt
Cancer cells exhibit dysregulation of critical genes including those involved in lipid biosynthesis, with subsequent defects in metabolism. Here, we show that ELOngation of Very Long chain fatty acids protein 4 (ELOVL4), a rate-limiting enzyme in the biosynthesis of very-long polyunsaturated fatty acids (n-3, ≥28 C), is expressed and transcriptionally repressed by the oncogene MYCN in neuroblastoma cells. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
